No Routine Cancer Screening Option? New MCED Tests May Help
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.
Stay updated with breaking news from Geneseeq Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.
The Toronto-based firm gained marketing clearance in Europe for two kits for profiling solid tumors and one kit for hematological cancer genomic profiling.
The global cancer diagnostics market is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion. Considering this increasing growth and demand in the global market, the canc...
The global cancer diagnostics market is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion. Considering this increasing growth and demand in the global market, the canc...
Research Report on Cell-Free DNA (cfDNA) Kits Market